| CAS ID: | 117-39-5 |
| Molecular Formula: | C15H10O7 |
| Molecular Weight: | 302.2 g/mol |
| Monoisotopic Mass: | 302.0427 g/mol |
| Class: | Small Molecule |
| Natural Product: | Yes |
| Other Names: | C.I. Natural Red 1 | Quercetin Dihydrate | Meletin | Sophoretin | Xanthaurine | NSC-9219 |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 28775044 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | |||
| Process II | cells apoptosis | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 2
| PubMed ID | 28549404 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | fibroblasts growth | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 3
| PubMed ID | 27286825 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Cystic fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | |||
| Mechanism | Targeting A20 | ||
Reference Record 4
| PubMed ID | 27052477 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Renal fibrosis |
| Process I | attenue inflammation | ||
| Process II | fibroblasts activation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Mammalian Target of Rapamycin and β-catenin signaling | ||
Reference Record 5
| PubMed ID | 26173740 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Corneal fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 6
| PubMed ID | 26151815 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,rat | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | EMT | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting mTORC1/p70S6K signaling | ||
Reference Record 7
| PubMed ID | 19474275 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT01348204 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | May 5, 2011 | Last Verified | January 31, 2012 |
| Sponsor | University of Alabama at Birmingham | ||
Trial Record 2
| ClinicalTrial ID | NCT02874989 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 1 | Status | Recruiting |
| First Received | August 22, 2016 | Last Verified | December 13, 2018 |
| Sponsor | Wake Forest University Health Sciences | ||